JESSICA KROP: Open Payments
NPI 1659043305 · GARNER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 22 payments from 10 companies in 2025. Trend: 2023 $119 · 2024 $596 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $135 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| ABBVIE INC. | 2 | $51 |
| Exact Sciences Corporation | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| Amgen Inc. | 1 | $23 |
| PhotoniCare Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Wegovy, AIRSUPRA, VRAYLAR, Ozempic, XIFAXAN, PENMENVY, REPATHA, Cologuard Collection Kit.
Industry payments across NC — which companies pay providers there.
